These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 7245230)

  • 1. Elimination pattern and biodistribution of [14C]chlorferron in rats.
    Malik JK; Lay JP; Klein W; Korte F
    Toxicol Lett; 1981 Mar; 7(6):449-52. PubMed ID: 7245230
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biotransformation and disposition of the coumaphos metabolite 3-chloro-4-methyl-(4-14C)-7-hydroxycoumarin in rats.
    Malik JK; Lay JP; Klein W; Korte F
    Arch Toxicol; 1981 Aug; 48(1):51-9. PubMed ID: 7283748
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Studies on 3-chloro-4-methyl-(4-14C)-7-hydroxycoumarin in rats.
    Malik JK; Lay JP; Klein W; Korte F
    Adv Exp Med Biol; 1981; 136 Pt A():839-46. PubMed ID: 7344495
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Absorption, distribution, metabolism, and excretion of N,N-diethyl-M-toluamide in the rat.
    Schoenig GP; Hartnagel RE; Osimitz TG; Llanso S
    Drug Metab Dispos; 1996 Feb; 24(2):156-63. PubMed ID: 8742226
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The disposition of radioactivity after administration of the anthelminthic methyl-14C-5-cyclopropylcarbonyl-2-benzimidazole carbamate (ciclobendazole) to rats and dogs.
    Brodie RR; Mayo BC; Chasseaud LF; Hawkins DR
    Arzneimittelforschung; 1977; 27(3):593-8. PubMed ID: 577426
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Elimination- and biodistribution studies of [14C]dodecylbenzene sulfonate in rats, following low dosing in the daily diet and a single i.p. administration.
    Lay JP; Klein W; Korte F
    Toxicol Lett; 1983 Jun; 17(1-2):187-92. PubMed ID: 6623504
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Blood level, distribution, excretion, and metabolite pattern of [14C]-brotizolam in the rat, dog, and rhesus monkey.
    Bechtel WD; Mierau J; Richter I; Stiasni M
    Arzneimittelforschung; 1986 Mar; 36(3A):568-74. PubMed ID: 3718579
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The fate of saccharin impurities. The excretion and metabolism of [14C]toluene-4-sulphonamide and 4-sulphamoyl[14C]benzoic acid in the rat.
    Ball LM; Williams RT; Renwick AG
    Xenobiotica; 1978 Mar; 8(3):183-90. PubMed ID: 654313
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Absorption, distribution, metabolism and excretion of glucosamine sulfate. A review.
    Setnikar I; Rovati LC
    Arzneimittelforschung; 2001 Sep; 51(9):699-725. PubMed ID: 11642003
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metabolism of [14C]emodin in the rat.
    Bachmann M; Schlatter C
    Xenobiotica; 1981 Mar; 11(3):217-25. PubMed ID: 7293218
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Absorption, distribution and excretion of 2,4-diamino-6-(2,5-dichlorophenyl)-s-triazine maleate in rats, dogs and monkeys.
    Ando T; Momota K; Sugiyama M
    Arzneimittelforschung; 1986 Aug; 36(8):1221-8. PubMed ID: 3778559
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The tissue distribution, metabolism, and excretion of octachlorostyrene in the rat.
    Chu I; Villeneuve DC; Secours V; Benoit FM; Viau A
    Drug Metab Dispos; 1982; 10(6):632-5. PubMed ID: 6130912
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Disposition and metabolism of the new hypocholesterolemic compound S-8921 in rats and dogs.
    Yamaguchi T; Nakajima Y; Mizobuchi M; Inazawa K; Kanazu T; Kadono K; Ohkawa T; Iwatani K
    Arzneimittelforschung; 1998 Oct; 48(10):995-1006. PubMed ID: 9825117
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetics and metabolism of fosmidomycin, a new phosphonic acid, in rats and dogs.
    Tsuchiya T; Ishibashi K; Terakawa M; Nishiyama M; Itoh N; Noguchi H
    Eur J Drug Metab Pharmacokinet; 1982; 7(1):59-64. PubMed ID: 7067725
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Disposition of 14C-alpha-cyclodextrin in germ-free and conventional rats.
    Van Ommen B; De Bie AT; Bär A
    Regul Toxicol Pharmacol; 2004 Jun; 39 Suppl 1():57-66. PubMed ID: 15265616
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metabolic fate of the thrombolytic agent benzarone in man: comparison with the rat and dog.
    Wood SG; John BA; Chasseaud LF; Bonn R; Grote H; Sandrock K; Darragh A; Lambe RF
    Xenobiotica; 1987 Jul; 17(7):881-96. PubMed ID: 3660858
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metabolism of N-[4-chloro-2-fluoro-5-[(1-methyl-2-propynyl)oxy]phenyl]-3,4,5,6- tetrahydrophthalimide (S-23121) in the rat. II. Absorption, disposition, excretion and biotransformation.
    Yoshino H; Kaneko H; Nakatsuka I; Yamada H
    Xenobiotica; 1993 Oct; 23(10):1075-84. PubMed ID: 8259690
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The fate of saccharin impurities: the excretion and metabolism of [3-14C]Benz[d]-isothiazoline-1,1-dioxide (BIT) in man and rat.
    Renwick AG; Williams RT
    Xenobiotica; 1978 Aug; 8(8):475-86. PubMed ID: 695691
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacokinetics of NS-105, a novel cognition enhancer. 1st communication: absorption, metabolism and excretion in rats, dogs and monkeys after single administration of 14C-NS-105.
    Mukai H; Sugimoto T; Ago M; Morino A
    Arzneimittelforschung; 1999 Nov; 49(11):881-90. PubMed ID: 10604039
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metabolism and tissue distribution of mono-2-ethylhexyl phthalate in the rat.
    Chu I; Villeneuve DC; Secours V; Franklin C; Rock G; Viau A
    Drug Metab Dispos; 1978; 6(2):146-9. PubMed ID: 26529
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.